Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rui Sun, Yating Wang & Hassan Abolhassani. (2023) Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies. Expert Review of Clinical Immunology 19:7, pages 771-784.
Read now
Read now
Yuwen Cao, Yu Tian, Yueqin Liu & Zhaoliang Su. (2022) Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. International Reviews of Immunology 41:2, pages 160-170.
Read now
Read now
Articles from other publishers (51)
Alankar Roy, Ishani Paul, Shreya Luharuka & Sujay Ray. (2023) An in-silico scaffold- hopping approach to design novel inhibitors against gp130: A potential therapeutic application in cancer and Covid-19. Molecular Diversity.
Crossref
Crossref
Siyuan Tan, Haodong Tang, Yang Wang, Peng Xie, Haifeng Li, Zheng Zhang & Jiahua Zhou. (2023) Tumor cell-derived exosomes regulate macrophage polarization: Emerging directions in the study of tumor genesis and development. Heliyon 9:9, pages e19296.
Crossref
Crossref
Yonghyun Lee, Jongyoon Shinn, Cheng Xu, Hannah E. Dobson, Nouri Neamati & James J. Moon. (2023) Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy. Nature Communications 14:1.
Crossref
Crossref
Xiaojuan Yang, Lu Xu, Li Yang & Shaohong Xu. (2023) Research progress of STAT3-based dual inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry 91, pages 117382.
Crossref
Crossref
Yaxian Wang, Xipeng Sun, Quanjun Yang & Cheng Guo. (2023)
Cucurbitacin
IIb
attenuates cancer cachexia induced skeletal muscle atrophy by regulating the
IL
‐6/
STAT3
/
FoxO
signaling pathway
. Phytotherapy Research 37:8, pages 3380-3393.
Crossref
Crossref
Ziyu Ji, Jianlin Shen, Yujian Lan, Qian Yi & Huan Liu. (2023) Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. MedComm 4:4.
Crossref
Crossref
Jiayu Bao, Peng Zhang, Binge Wu, Jingyi Wang, Siyuan Li, Ao Li & Ying Jie. (2023) Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science 64:4, pages 5.
Crossref
Crossref
Yanesko Fernandes Bella, Carlos Rocha Oliveira, José Roberto Mateus-Silva, Maysa Alves Rodrigues Brandao-Rangel, Anamei Silva-Reis, Juliana de Melo Batista Santos, Regiane Albertini, Rodrigo Alvaro Brandao Lopes-Martins, Luis Vicente Franco de Oliveira & Rodolfo P. Vieira. (2023) A phytotherapic blend immunity-6™ inhibits myeloid leukemic cells 2 activation involving purinergic signaling. Biomedicine & Pharmacotherapy 159, pages 114263.
Crossref
Crossref
Ioannis Pozios, Nina A. Hering, Emily Guenzler, Marco Arndt, Sefer Elezkurtaj, Thomas Knösel, Christiane J. Bruns, Georgios A. Margonis, Katharina Beyer & Hendrik Seeliger. (2022) Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144. Journal of Cancer Research and Clinical Oncology 149:1, pages 271-280.
Crossref
Crossref
Yuwaraj Kadariya, Eleonora Sementino, Ujjawal Shrestha, Greg Gorman, Jonathan M White, Eric A Ross, Margie L Clapper, Nouri Neamati, Mark Steven Miller & Joseph R Testa. (2022) Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma. Carcinogenesis 43:12, pages 1137-1148.
Crossref
Crossref
Sujay Ray & Shreya Luharuka. (2022) Targeting the gp130_D5 domain through pharmacophore modelling and structure-based virtual screening using natural plant products: A detailed molecular dynamics study for development of novel anti-cancer therapeutics. Journal of Molecular Graphics and Modelling 117, pages 108290.
Crossref
Crossref
Md. Hafiz Uddin, Md. Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel El-Rayes & Asfar S. Azmi. (2022) Aberrant transcription factors in the cancers of the pancreas. Seminars in Cancer Biology 86, pages 28-45.
Crossref
Crossref
Jiangyan Xu, Jinrong Zhang, Qi-Fen Mao, Jian Wu & Yuan Wang. (2022) The Interaction Between Autophagy and JAK/STAT3 Signaling Pathway in Tumors. Frontiers in Genetics 13.
Crossref
Crossref
Douglas L. Mann. (2022) Targeting Inflammation in Pulmonary Artery Hypertension: Is It Time to Forget About the Lungs?. Circulation: Heart Failure 15:1.
Crossref
Crossref
Hua Yu Ling, Zhong Yang, Pan Jun Wang, Yu Sun, Song Guang Ju, Jun Li & Jin Xiang Fu. (2022) Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway. Chemico-Biological Interactions 352, pages 109779.
Crossref
Crossref
Xiaoqing Fan, Haoran Yang, Chenggang Zhao, Lizhu Hu, Delong Wang, Ruiting Wang, Zhiyou Fang & Xueran Chen. (2021) Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Sarah Peisl, Claudia Mellenthin, Lucie Vignot, Carmen Gonelle-Gispert, Leo Bühler & Bernhard Egger. (2021) Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. PLOS ONE 16:6, pages e0252397.
Crossref
Crossref
Huan Liu, Wenlong Lin, Zhiyong Liu, Yinjing Song, Hao Cheng, Huazhang An & Xiaojian Wang. (2021) E3 ubiquitin ligase NEDD4L negatively regulates keratinocyte hyperplasia by promoting GP130 degradation. EMBO reports 22:5.
Crossref
Crossref
Rosa K. Kortekaas, Janette K. Burgess, Roël van Orsoy, David Lamb, Megan Webster & Reinoud Gosens. (2021) Therapeutic Targeting of IL-11 for Chronic Lung Disease. Trends in Pharmacological Sciences 42:5, pages 354-366.
Crossref
Crossref
Narges Rostami, Afshin Nikkhoo, Yalda Khazaei‐poul, Shohreh Farhadi, Melika Sadat Haeri, Sadaf Moghadaszadeh Ardebili, Nasimeh Aghaei Vanda, Fatemeh Atyabi, Afshin Namdar, Masoumeh Baghaei, Navideh Haghnavaz, Tohid Kazemi, Mehdi Yousefi, Ghasem Ghalamfarsa, Gholamabas Sabz & Farhad Jadidi‐Niaragh. (2020) Coinhibition of S1PR1 and GP130 by siRNA‐loaded alginate‐conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells. Journal of Cellular Physiology 235:12, pages 9702-9717.
Crossref
Crossref
Sebastiano Andò, Giuseppina Daniela Naimo, Luca Gelsomino, Stefania Catalano & Loredana Mauro. (2020) Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression. Obesity Reviews 21:5.
Crossref
Crossref
Xuanhao Li, Shanshan He, Ye Tian, Robert M. Weiss & Darryl T. Martin. (2019) Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth. Cellular Signalling 63, pages 109381.
Crossref
Crossref
Fangming Liu, Haizhen Jin, Jinhong Shen, Dan Wu, Ye Tian & Chao Huang. (2019) Gp130 degradation induced by epirubicin contributes to chemotherapy efficacy. Biochemical and Biophysical Research Communications 519:3, pages 572-578.
Crossref
Crossref
Payal Tiwari, Ariane Blank, Chang Cui, Kelly Q. Schoenfelt, Guolin Zhou, Yanfei Xu, Galina Khramtsova, Funmi Olopade, Ajay M. Shah, Seema A. Khan, Marsha Rich Rosner & Lev Becker. (2019) Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer. Journal of Experimental Medicine 216:6, pages 1345-1358.
Crossref
Crossref
Xiang Chen, Jilai Tian, Gloria H. Su & Jiayuh Lin. (2019) Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells. Current Cancer Drug Targets 19:5, pages 417-427.
Crossref
Crossref
Darryl T. Martin, Hongliang Shen, Jill M. Steinbach-Rankins, Xi Zhu, Katelyn K. Johnson, Jamil Syed, W. Mark Saltzman & Robert M. Weiss. (2019) Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target. Molecular Cancer Therapeutics 18:2, pages 413-420.
Crossref
Crossref
Ali Masjedi, Vida Hashemi, Mohammad Hojjat-Farsangi, Ghasem Ghalamfarsa, Gholamreza Azizi, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2018) The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomedicine & Pharmacotherapy 108, pages 1415-1424.
Crossref
Crossref
Kriti Ray, Beata Ujvari, Venkata Ramana & John Donald. (2018) Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer. Cytokine & Growth Factor Reviews 41, pages 18-27.
Crossref
Crossref
Sunyoung Ham, Luize G. Lima, Edna Pei Zhi Chai, Alexandra Muller, Richard J. Lobb, Sophie Krumeich, Shu Wen Wen, Adrian P. Wiegmans & Andreas Möller. (2018) Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling. Frontiers in Immunology 9.
Crossref
Crossref
Weihua Zhu, Yazhou Wang, Dafang Zhang, Xin Yu & Xisheng Leng. (2018) MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma. Biochemical and Biophysical Research Communications 497:4, pages 963-970.
Crossref
Crossref
Jean-Marc Cavaillon & Mervyn SingerToshio Tanaka, Masashi Narazaki & Tadamistu Kishimoto. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
573
586
.
Xiang Chen, Jia Wei, Chenglong Li, Christopher Pierson, Jonathan Finlay & Jiayuh Lin. (2017) Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells. International Journal of Oncology.
Crossref
Crossref
Hui Xiao, Hemant Kumar Bid, Xiang Chen, Xiaojuan Wu, Jia Wei, Yang Bian, Chengguang Zhao, Huameng Li, Chenglong Li & Jiayuh Lin. (2017) Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy. PLOS ONE 12:7, pages e0180297.
Crossref
Crossref
Yanyan Yuan, Yang Xi, Jiayi Chen, Pan Zhu, Jinyu Kang, Zuquan Zou, Fuyan Wang & Shizhong Bu. (2017) STAT3 stimulates adipogenic stem cell proliferation and cooperates with HMGA2 during the early stage of differentiation to promote adipogenesis. Biochemical and Biophysical Research Communications 482:4, pages 1360-1366.
Crossref
Crossref
Manica Negahdaripour, Navid Nezafat & Younes Ghasemi. (2016) A panoramic review and in silico analysis of IL-11 structure and function. Cytokine & Growth Factor Reviews 32, pages 41-61.
Crossref
Crossref
Teresa A. Zimmers, Melissa L. Fishel & Andrea Bonetto. (2016) STAT3 in the systemic inflammation of cancer cachexia. Seminars in Cell & Developmental Biology 54, pages 28-41.
Crossref
Crossref
Dixon H. Xu, Ziwen Zhu, Mark R. Wakefield, Huaping Xiao, Qian Bai & Yujiang Fang. (2016) The role of IL-11 in immunity and cancer. Cancer Letters 373:2, pages 156-163.
Crossref
Crossref
Tae-Hwe Heo, Joseph Wahler & Nanjoo Suh. (2016) Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer. Oncotarget 7:13, pages 15460-15473.
Crossref
Crossref
Steffanie L. Furtek, Donald S. Backos, Christopher J. Matheson & Philip Reigan. (2016) Strategies and Approaches of Targeting STAT3 for Cancer Treatment. ACS Chemical Biology 11:2, pages 308-318.
Crossref
Crossref
Mark R. Walter. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
124
133
.
Mans Broekgaarden, Ruud Weijer, Thomas M. van Gulik, Michael R. Hamblin & Michal Heger. (2015) Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer and Metastasis Reviews 34:4, pages 643-690.
Crossref
Crossref
Cameron N. Johnstone, Ashwini Chand, Tracy L. Putoczki & Matthias Ernst. (2015) Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer. Cytokine & Growth Factor Reviews 26:5, pages 489-498.
Crossref
Crossref
Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, Yeon-Hwa Park, Kyung-Yeon Park, Joo Young Lee, Juyoung Kim, Veeraswamy Gajulapati, Ja-Il Goo, Sarbjit Singh, Kyeong Lee, Young-Kook Kim, So Hee Im, Sung-Hoon Ahn, Stefan Rose-John, Tae-Hwe Heo & Yongseok Choi. (2015) A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130. The Journal of Immunology 195:1, pages 237-245.
Crossref
Crossref
S Xu, H Adisetiyo, S Tamura, F Grande, A Garofalo, P Roy-Burman & N Neamati. (2015) Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer. British Journal of Cancer 113:2, pages 242-251.
Crossref
Crossref
Mariann F. Hansen, Eva Greibe, Signe Skovbjerg, Sarah Rohde, Anders C.M. Kristensen, Trine R. Jensen, Charlotte Stentoft, Karina H. Kjær, Camilla S. Kronborg & Pia M. Martensen. (2015) Folic acid mediates activation of the pro-oncogene STAT3 via the Folate Receptor alpha. Cellular Signalling 27:7, pages 1356-1368.
Crossref
Crossref
Tracy L Putoczki & Matthias Ernst. (2015) IL-11 signaling as a therapeutic target for cancer. Immunotherapy 7:4, pages 441-453.
Crossref
Crossref
Jana Pastuschek, Jenny Poetzsch, Diana M. Morales-Prieto, Ekkehard Schleußner, Udo R. Markert & Georgi Georgiev. (2015) Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434. Journal of Reproductive Immunology 108, pages 48-55.
Crossref
Crossref
Timo Rath, Ulrike Billmeier, Maximilian J. Waldner, Raja Atreya & Markus F. Neurath. (2015) From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis. Archives of Toxicology 89:4, pages 541-554.
Crossref
Crossref
Irma Airoldi, Maria Grazia Tupone, Silvia Esposito, Marco V. Russo, Giulia Barbarito, Giuseppe Cipollone & Emma Di Carlo. (2015) Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer. Oncotarget 6:6, pages 3694-3708.
Crossref
Crossref
Ana P. Costa-Pereira. (2014) Regulation of IL-6-type cytokine responses by MAPKs. Biochemical Society Transactions 42:1, pages 59-62.
Crossref
Crossref
Koji Taniguchi & Michael Karin. (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Seminars in Immunology 26:1, pages 54-74.
Crossref
Crossref